Susquehanna International Group’s Revelation Biosciences Warrant REVBW Stock Holding History

Susquehanna International Group’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33,468	Closed	-$402	–	13661
2025 Q2	$402	Buy	+33,468	New	+$405	﹤0.01%	12528
2024 Q3	–	Sell	-14,575	Closed	-$292	–	12862
2024 Q2	$292	Buy	+14,575	New	+$238	﹤0.01%	11893
2022 Q3	–	Sell	-14,418	Closed	-$1K	–	13965
2022 Q2	$1K	Buy	+14,418	New	+$1.21K	﹤0.01%	12726
2021 Q4	–	Sell	-19,236	Closed	-$12K	–	13771
2021 Q3	$12K	Buy	19,236 +7,972	+71%	+$4.83K	﹤0.01%	12595
2021 Q2	$7K	Buy	+11,264	New	+$6.71K	﹤0.01%	12452

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PIS

POM Investment Strategies Raleigh, North Carolina $80.5M AUM 16.64% 1-Year Est. Return

Susquehanna International Group's REVBW Position: Q3 2025 in Review

Susquehanna International Group sold out of Revelation Biosciences Warrant (REVBW) in Q3 2025, closing a stake of 33,468 shares — an estimated $402 sold.

Susquehanna International Group first reported a position in REVBW in Q2 2021 and held it in 5 quarters. The position peaked at $12K in Q3 2021. 11 funds tracked by Wall St. Rank hold REVBW as of Q3 2025.

Susquehanna International Group reported no remaining Revelation Biosciences Warrant position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 33,468 Revelation Biosciences Warrant shares in Q3 2025, an estimated $402.
Susquehanna International Group first reported a position in Revelation Biosciences Warrant in Q2 2021 and held it in 5 quarters.
Susquehanna International Group's Revelation Biosciences Warrant position peaked at $12K in Q3 2021.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.